Dyskinesia, Drug-InducedKartagener SyndromeDyskinesiasBiliary DyskinesiaLevodopaCiliary Motility DisordersAntiparkinson AgentsAxonemal DyneinsChoreaBenserazideMovement DisordersParkinsonian DisordersCiliaAntipsychotic AgentsParkinson DiseaseOxidopamineSitus InversusParkinson Disease, SecondaryAkathisia, Drug-InducedAxonemeCorpus StriatumCarbidopaDopamine AgentsEpilepsy, Benign NeonatalDyneinsMPTP PoisoningDopamine AgonistsSchizophreniaTranquilizing AgentsAdrenergic Agents1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineDystoniaBasal Ganglia DiseasesSerotonin 5-HT1 Receptor AgonistsMucociliary ClearancePhenothiazinesGlobus PallidusHaloperidolBronchiectasisAmantadineSubthalamic NucleusDynorphinsNasal CavityReceptor, Serotonin, 5-HT1ABenzothiazolesApomorphineReceptors, Dopamine D1CallithrixReceptors, Dopamine D3Neostriatum8-Hydroxy-2-(di-n-propylamino)tetralinReceptors, DopamineTiapamil HydrochlorideBasal GangliaMetoclopramideSubstantia NigraSerotonin AgentsAmishNeurologic ExaminationMedial Forebrain BundleNortropanesDopamineSphincter of OddiMotor ActivityExomeSerotonin Receptor AgonistsPedigreeTetrabenazinePiribedilDopamine and cAMP-Regulated Phosphoprotein 32Stereotyped BehaviorReceptors, Dopamine D2Heterotaxy SyndromeAphakiaCommon Bile Duct DiseasesDeep Brain StimulationRisperidoneG-Protein-Coupled Receptor KinasesDisease Models, AnimalSperm TailSphincter of Oddi DysfunctionRats, Sprague-DawleyRespiratory System5,7-DihydroxytryptamineAdenosine A2 Receptor AntagonistsMacaca fascicularisParasympathomimeticsMutationBehavior, AnimalEntopeduncular NucleusPsychotic DisordersCommunity Mental Health CentersSeverity of Illness IndexNasal MucosaFacial Nerve DiseasesBreath TestsDose-Response Relationship, DrugAnti-Dyskinesia Agents